Prophylactic nitroglycerin infusions during coronary artery bypass surgery.
The effects of prophylactic infusion of 1 microgram X kg-1 X min-1 nitroglycerin (NTG) on the incidence of ischemia, hypertension, hypotension and perioperative myocardial infarction were studied in 81 patients during coronary artery bypass grafting (CABG). Forty-one patients (Group 1) received NTG and 40 patients (Group 2) received placebo. All patients received fentanyl for anesthesia and pancuronium. Mean arterial pressure (MAP), pulmonary capillary wedge pressure (PCWP), heart rate (HR), and cardiac output (CO) were measured before and after induction of anesthesia, after intubation, before and after chest incision, after sternotomy, after the pericardium was opened, and during normothermic cardiopulmonary bypass. Myocardial ischemia and infarction were diagnosed from the ECG, hypertension was defined as a 20% increase in MAP, and hypotension was defined as a 20% decrease in MAP compared with preinduction values. No significant differences between Groups 1 and 2 in HR, PCWP, or CO were seen. MAP was significantly lower in Group 1 than Group 2 (P less than 0.05) before chest incision, but increased to levels equal to Group 2 after sternotomy. Hypertension occurred in 32 Group 2 patients and 25 Group 1 patients (0.05 less than P less than 0.1). Group 1 patients had 0.95 +/- 0.14 episodes per patient of hypertension, while Group 2 patients had 2.10 +/- 0.31 episodes (P less than 0.05). Hypotension occurred in 20 Group 1 patients but only six Group 2 patients (P less than 0.05). There was no difference in the incidence of ischemia. In Group 1, nine patients (22%) had ECG changes of ischemia, while 12 patients in Group 2 (30%) had ischemia.(ABSTRACT TRUNCATED AT 250 WORDS)
D000758:Anesthesia; D002302:Cardiac Output; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000517:prevention & control; D003402:Creatine Kinase / Q000097:blood; D004562:Electrocardiography; D005283:Fentanyl; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D007022:Hypotension / Q000517:prevention & control; D005996:Nitroglycerin / Q000627:therapeutic use*; D010197:Pancuronium; D011669:Pulmonary Wedge Pressure; D013610:Tachycardia / Q000517:prevention & control
D003402:Creatine Kinase; D005996:Nitroglycerin; D010197:Pancuronium; D005283:Fentanyl